By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Fluvastatin

Fluvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|664 words

Fluvastatin

What is Fluvastatin?

Fluvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated blood cholesterol. Fluvastatin was the first fully synthetic statin approved for medical use and remains an effective option for managing dyslipidemia.

Uses

  • Primary hypercholesterolemia: Treatment of high cholesterol levels in patients who have not responded adequately to dietary changes and lifestyle modifications
  • Mixed dyslipidemia: Management of patients with elevated total cholesterol, LDL cholesterol, and triglycerides, while helping to raise HDL cholesterol levels
  • Secondary prevention of cardiovascular events: Reduction of risk for heart attack, stroke, and other cardiovascular complications in patients with existing coronary heart disease
  • Primary prevention in high-risk patients: Prevention of cardiovascular events in patients without existing heart disease but with multiple risk factors such as diabetes, hypertension, or family history
  • Slowing progression of atherosclerosis: Helping to reduce the buildup of plaque in arterial walls and potentially reversing some existing atherosclerotic changes

How it works

Fluvastatin works by inhibiting HMG-CoA reductase, a key enzyme responsible for cholesterol production in the liver. By blocking this enzyme, the medication significantly reduces the liver’s ability to manufacture cholesterol, which forces the liver to remove more cholesterol from the bloodstream. This dual action results in lower total cholesterol and LDL (“bad”) cholesterol levels while providing additional cardiovascular protective effects beyond cholesterol reduction.

Side effects

Common side effects:

  • Headache
  • Muscle aches or weakness
  • Abdominal pain or discomfort
  • Nausea and digestive upset
  • Fatigue or weakness
  • Diarrhea
  • Upper respiratory tract symptoms
  • Dizziness

Serious side effects to watch for:

Submit Your Paper
GMJ_Submit_Banner
  • Severe muscle pain, tenderness, or weakness (potential rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (signs of liver problems)
  • Unexplained persistent fatigue or weakness
  • Memory problems or confusion

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained persistent elevations in liver enzymes should not take fluvastatin. Regular liver function monitoring may be required during treatment.
  • Pregnancy and breastfeeding: Fluvastatin is contraindicated during pregnancy and breastfeeding as it may harm fetal development. Women of childbearing age should use effective contraception during treatment.
  • Muscle disorders: Patients with a history of muscle disorders or those taking medications that increase the risk of muscle problems should be monitored closely for signs of myopathy.
  • Kidney impairment: Dose adjustments may be necessary in patients with severe kidney disease, and these patients require closer monitoring.
  • Alcohol consumption: Excessive alcohol use should be avoided as it may increase the risk of liver complications when combined with statin therapy.

Interactions

  • Warfarin: Fluvastatin may enhance the anticoagulant effects of warfarin, requiring more frequent INR monitoring and possible dose adjustments
  • Fibrates (gemfibrozil, fenofibrate): Combination increases the risk of muscle toxicity and rhabdomyolysis
  • Cyclosporine: Can significantly increase fluvastatin levels in the blood, raising the risk of adverse effects
  • Rifampin: This antibiotic may reduce fluvastatin effectiveness by increasing its metabolism
  • Phenytoin: Fluvastatin may increase phenytoin levels, potentially leading to toxicity
  • Glyburide: Enhanced blood sugar-lowering effects may occur when combined with this diabetes medication
  • Grapefruit juice: Large amounts may increase fluvastatin levels, though the interaction is less significant than with other statins
  • Niacin (high doses): Combination therapy may increase the risk of muscle-related side effects

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 20-40 mg taken once daily in the evening, as cholesterol production is highest during nighttime hours. The dose may be gradually increased up to a maximum of 80 mg daily based on individual response and cholesterol targets. Extended-release formulations are usually taken once daily and may provide more consistent cholesterol control. Dosage adjustments should always be made under medical supervision, with cholesterol levels typically checked every 6-8 weeks until target levels are achieved.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Fluvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/fluvastatin-3/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Rosuvastatin

By
GMJ News Desk
01/06/2026

Pitavastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026

Pitavastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up